Kristopher Sturgis

Two Companies Come Together on New Prosthetic Technology

Posted in by Kristopher Sturgis on August 16, 2017
Coapt and WillowWood are developing a liner for upper extremity prosthetic devices that combines the benefits of interface and pattern recognition technologies.Kristopher Sturgis Coapt and WillowWood expect to release a new liner product for upper extremity prosthetic devices by 2018. Two ... Continue

Q&A: Meet University of Minnesota’s Nanotech Expert

Posted in by Kristopher Sturgis on August 14, 2017
James Marti, the senior scientist at the Minnesota Nano Center, speaks about some of the small but mighty materials that could lead to big advances in the medtech market.Kristopher SturgisWhen it comes to the future of medtech, there’s no denying that the impact that materials at the micro and nan... Continue

Could Hydrogel Solve a Major Medication Problem?

Posted by Kristopher Sturgis on August 9, 2017
 Researchers from MIT created hydrogel-based capsules that can reside in the GI tract for up to nine days while releasing its medication — enabling more complex drug dose regimens.Kristopher SturgisJinyao Liu, left, and Giovanni Traverso, researchers at MIT and Brigham and Women's Hospital, d... Continue

Is This the Key to Better Condoms and Catheters?

Posted in by Kristopher Sturgis on July 26, 2017
MIT engineers are working on a new hydrogel that could improve a diverse range of medical devices, including condoms and catheters.Kristopher SturgisMIT engineering students created a gel-like material to coat standard plastic tubes and rubber devices to ease patient comfort.  When it come... Continue

Is Boston Scientific Taking a Shine to the Bladder Market?

Posted by Kristopher Sturgis on July 24, 2017
Boston Scientific led a $35.5 million funding round to support Amphora Medical's bladder denervation study.Kristopher SturgisAmphora Medical said its recent $35.5 million funding round will support a U.S. study of Selective Bladder Denervation System for women suffering from an overactive bladder.&n... Continue

Is Micro-Sensing the Answer to Early Stroke Treatment?

Posted by Kristopher Sturgis on July 19, 2017
A new technology in development by Sensome aims to reliably identify biological tissue to help doctors understand the composition of blood clots that result in stroke — leading to quicker and more effective treatment.Kristopher Sturgis Sensome, a company focused on developing new micro-sensor... Continue

FDA Exempts Over 1000 Devices from 510(k) Requirement

Posted in by Kristopher Sturgis on July 11, 2017
The 21st Century Cures Act paved the way for deregulation of a host of medical devices ranging from surgical lights to dentures.Kristopher SturgisFDA announced this week a list of more than 1,000 medical devices that will now be exempt from 510(k) notification requirements — a move that aims ... Continue

How a Camera is Bridging Healthcare and Criminal Justice

Posted in by Kristopher Sturgis on July 10, 2017
A new high-tech photo documentation system at Cleveland Clinic can examine and capture biological evidence that often goes unseen by current methods.  Kristopher SturgisA new photo documentation system is helping Cleveland Clinic forensic nurses document evidence that the naked eye misses.... Continue

Philips Scores FDA Clearance for Informatics Platform

Posted in by Kristopher Sturgis on July 5, 2017
Clearance for the IntelliSpace Portal 9.0 opens the door for a range of new applications for radiology, neurology, oncology, and cardiology.Kristopher SturgisThe newest FDA-cleared application for Philips' Intellispace Portal is the Longitudinal Brain Imaging (LoBI). FDA has cleared a new compr... Continue

Is Medtronic Gearing Up to Buy Glooko?

Posted in by Kristopher Sturgis on June 30, 2017
The diabetes data management company aims to expand its sales, marketing, and development teams through new investors to deepen its expertise in data analytics.Kristopher SturgisGlooko's latest funding round secures its position in the market as the company goes up against larger competitors, such a... Continue